UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
AbbVie says its psoriasis drug superior to Novartis’ treatment
AbbVie said its psoriasis treatment Skyrizi met both primary and all-ranked...
by Lee Han-soo
|
2020-01-17 17:28
라인
HanAll, Daewoong unveil P3 topline results for dry eye treatment
HanAll Biopharma and Daewoong Pharmaceutical said that they have presented ...
by Lee Han-soo
|
2020-01-16 15:46
라인
Genome to conduct immunotherapy combo trial with Merck, Pfizer
Genome & Company, a local clinical-stage biotechnology business, said that ...
by Lee Han-soo
|
2020-01-16 14:47
라인
GSK to target ovarian cancer, multiple myeloma, endometrial cancer
After entering the oncology market with the acquisition of Tesaro in late 2...
by Kim Yun-mi
|
2020-01-16 14:10
라인
Sweden prolongs financial support for IVI’s vaccine development
The International Vaccine Institute (IVI) said that the Swedish Internation...
by Lee Han-soo
|
2020-01-16 10:45
라인
Pharmaceutical association lays out plans for 2020
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) l...
by Lee Han-soo
|
2020-01-15 14:29
라인
AptaBio attending J.P. Morgan event for global collaboration
AptaBio, a maker of drugs to treat cancer and diabetic complications, said ...
by Shim Hyun-tai
|
2020-01-15 13:06
라인
GC Pharma's US offshoot opens new plasma center
GC Pharma said Green Cross America (GCAM), its U.S. branch to secure plasma...
by Shim Hyun-tai
|
2020-01-15 13:05
라인
Jeil, Oncocross to discover new indications for stroke therapy
Jeil Pharmaceutical said that it will partner with Oncocross, a local ventu...
by Lee Han-soo
|
2020-01-15 11:31
라인
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
MSD is expected to announce the results of a study, whether Steglatro (ingr...
by Kim Yun-mi
|
2020-01-14 15:28
라인
Genexine becomes largest shareholder of GenNBio
GenNBio said that Genexine has become its largest shareholder. The announce...
by Lee Han-soo
|
2020-01-14 11:11
라인
Daewoong, A2A to develop AI-based anticancer treatment
Daewoong Pharmaceutical said that it would develop an anticancer treatment ...
by Lee Han-soo
|
2020-01-14 10:35
라인
GSK shows meaningful response rate for treatment of multiple myeloma
GSK Korea said that treatment with the investigational single-agent belanta...
by Lee Han-soo
|
2020-01-13 17:48
라인
Zejula widens indication as monotherapy for ovarian cancer
Takeda’s PARP (poly ADP-ribose polymerase) inhibitor Zejula (ingredient: ni...
by Kim Yun-mi
|
2020-01-13 16:25
라인
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint
Vivozon said that it has started on a design change for its phase 3b clinic...
by Lee Han-soo
|
2020-01-13 16:22
라인
Lilly secures atopic dermatitis drug through Dermira acquisition
Lilly has enhanced its immune disease pipelines by obtaining the rights to ...
by Kim Yun-mi
|
2020-01-13 14:05
라인
Latecomer Bavencio improves overall survival in bladder cancer trial
Bavencio (ingredient: avelumab), a latecomer in the Tecentriq-led immune ch...
by Kim Yun-mi
|
2020-01-10 14:23
라인
HLB gets UAE’s nod for joint company with local partner
Elevar therapeutics, a U.S. subsidiary of HLB, said that the United Arab Em...
by Lee Han-soo
|
2020-01-08 16:31
라인
Daewoong, Avacta to establish joint venture
Daewoong Pharmaceutical said that it plans to set up a joint venture (JV) w...
by Lee Han-soo
|
2020-01-08 12:25
라인
Genexine licenses out immunosuppressant candidate to GenNBio
Genexine said that it has licensed out BSF-110, a dual-fusion immunosuppres...
by Lee Han-soo
|
2020-01-07 17:35
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top